Research Opportunities
Partner With Denver Health
Leader in Clinical Trials
Experienced research staff and diverse patient population.
Get Started in Only 8 Weeks
Fast onboarding and to get your trial underway.
What To Expect When Working with Us
- 6–8 weeks startup! Our processes get your trial open quickly with a track record of up to just eight weeks.
- Diverse patients deliver more inclusive data. We serve a uniquely diverse, often underserved population, helping you meet enrollment goals and support regulatory expectations.
- Experienced team that has worked with all major industry and CRO partners.
Built for Studies That Need Speed and Real-World Relevance
If your protocol needs to open quickly and recruit across a broad, diverse population, Denver Health is the strong site choice.
Proven Ability to Support Impactful Trials
Our team participated in the early, global, adaptive trial for Remdesivir — one of the first COVID-19 drugs approved in the U.S. — and was among the first to start up and a top enroller. We can bring that same execution to your study.
Therapeutic and Sponsor Flexibility
We’re a fit for pharmaceutical companies and CROs conducting Phase II–IV, adaptive, and cardiology and oncology-based studies that need speed and dependable enrollment.
- Cardiology, oncology and other high-need areas
- Complex, adaptive trials
- Enrollment targets that require diverse participants
